๐ฐ Gamida Cell News
Page 2 - Gamida Cell News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Gamida Cell. Real-time updates on events, politics, business and more.
March 27, 2024
Gamida Cell Ltd. GMDA shares are plunging in the morning session on Wednesday. The company said it entered into a restructuring support agreement with certainโฆ
March 27, 2024
Reddit stock is a hot topic among traders on Wednesday after one analyst warns that RDDT could give up 50% of its gains.
March 13, 2024
/PRNewswire/ -- The "Global Cord Blood & Tissue Banking Industry Report - Market Size, Segmentation, & Forecasts, 2024" report has been added to...
February 23, 2024
Expanded access program (EAP) data for omidubicel are consistent with Phase 3 trial results on rates of hematopoietic recovery and infections following stemโฆ
January 31, 2024
Gamida Cell Ltd. (NASDAQ:GMDA – Get Free Report) saw a large growth in short interest during the month of January. As of January 15th, there was short interest totalling 7,930,000 shares, a growth of 19.1% from the December 31st total of 6,660,000 shares. Based on an average daily trading volume, of 2,940,000 shares, the short-interest […]
January 29, 2024
Gamida Cell Ltd. (GMDA) said it is actively pursuing strategic alternatives in order to maximize value for all stakeholders, focusing on an asset sale, merger or other strategic transaction.
January 29, 2024
Gamida Cell (NASDAQ:GMDA – Get Free Report)‘s stock had its “market perform” rating restated by equities research analysts at JMP Securities in a research report issued on Monday, Benzinga reports. A number of other research analysts have also recently commented on GMDA. Piper Sandler dropped their target price on shares of Gamida Cell from $5.00 […]
December 20, 2023
Dr. Margolin brings 35 years of expertise in biotechnology, pharma, and venture capital Purple Biotech also announces the resignation of Mr. Fabien Sebille, who served as the Companyโs Chief...
December 8, 2023
Candel Therapeutics (NASDAQ:CADL – Get Free Report) and Gamida Cell (NASDAQ:GMDA – Get Free Report) are both small-cap medical companies, but which is the superior investment? We will compare the two companies based on the strength of their valuation, profitability, dividends, risk, analyst recommendations, earnings and institutional ownership. Institutional & Insider Ownership 18.2% of Candel […]